Can Men Take Wegovy for Weight Loss?

Is Wegovy actually licensed for men, or is it mainly studied in women?

Wegovy is licensed in the UK for adults, full stop. The licence does not restrict use by sex. Novo Nordisk's STEP programme, which underpinned the NICE recommendation for semaglutide in weight management, enrolled both men and women across its trials. STEP 1, the largest of the phase 3 studies, randomised just over 1,900 adults without diabetes. Men were included throughout.

The mechanism is the same in men and women: semaglutide acts on GLP-1 receptors in the gut and brain, slowing gastric emptying and signalling fullness to the hypothalamus. The body's hormonal response to those signals does not depend on sex. What does vary is starting weight, lean muscle mass and metabolic rate, all of which can affect how quickly the numbers on the scale move. Men often carry more muscle and have a higher baseline metabolic rate, so the pattern of weight loss can look different even when the percentage reduction is similar.

If you are trying to understand how Wegovy performs specifically in men, the short answer is that the trial evidence supports it working well, and no male-specific contraindication exists in the product licence. A prescriber looks at your full clinical picture, not your sex, when deciding whether to approve treatment.

What do men need to meet the eligibility criteria for Wegovy?

The private licensed eligibility criteria are set by the medicine's SmPC. For Wegovy, that means a BMI of 30 or above, or a BMI of 27 to 29.9 alongside at least one weight-related health condition. Qualifying conditions include type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea and osteoarthritis, among others. For some ethnic backgrounds, UK guidance applies a threshold 2.5 kg/m² lower than the headline numbers.

BMI is a starting point, not the whole story. A prescriber also reviews your medical history, any medicines you currently take, and whether there are reasons Wegovy would not be suitable, such as a personal or family history of medullary thyroid carcinoma or MEN2 syndrome, or a history of pancreatitis. The full picture of who can take semaglutide is worth reading before your consultation, as it covers contraindications that apply to men and women equally.

One thing that sometimes catches men off guard: Wegovy is a prescription-only medicine. You cannot purchase it across a pharmacy counter or from a website that offers it without a formal clinical assessment. Any seller offering these injections without a prescriber's review is operating outside UK law, and the MHRA has received reports of counterfeit pens causing serious harm. Checking that your pharmacy is registered on the GPhC register before you order is a straightforward step that protects you.

What side effects should men be aware of, and how is the dose managed?

The side-effect profile for Wegovy is the same regardless of sex. Gastrointestinal symptoms are the most commonly reported: nausea, loose stools, constipation, indigestion and burping tend to be most noticeable in the first few weeks or after a dose increase, and for most people they settle as the body adjusts. Fatigue, headache and injection-site reactions are also reported. Nausea in particular can come as a surprise if you have never taken a GLP-1 medicine before, though it rarely stops people continuing treatment once they know what to expect.

Treatment starts at 0.25mg weekly, a dose whose job is to let your system adapt rather than drive weight loss immediately. The prescriber then titrates upward, roughly every four weeks, toward the 2.4mg maintenance dose. The timing and routine around each injection matter too: consistency on the same day each week, and keeping the pen in the fridge between uses, helps both the medicine and the habit stick. Many men find storing it in the fridge door alongside other weekly staples makes it easy to remember.

The MHRA issued updated guidance in January 2026 on acute pancreatitis as a known, serious but infrequent risk with GLP-1 medicines. Severe stomach pain that extends through to the back, with or without vomiting, calls for prompt medical attention. Your prescriber and the patient information leaflet will cover this and what else to watch for. If you want to look at the broader overview of Wegovy before booking a consultation, that page covers the full picture.

Can men get Wegovy on the NHS, and what is the private route?

NICE recommended semaglutide (TA875) for NHS use through specialist weight management services, with a maximum treatment duration of two years and a requirement for multidisciplinary support. NHS access for men and women follows the same criteria: BMI of 35 or above with at least one weight-related comorbidity is the headline threshold, though ethnic-background adjustments apply. Waiting lists for specialist services are commonly long, and not every area has the same capacity.

Private treatment removes the referral and the wait. Through a regulated online pharmacy, a GPhC-registered prescriber reviews your consultation answers the same day and, if treatment is suitable, the prescription is issued and dispatched quickly. The semaglutide treatment page gives a clear account of how the process works, and information on getting Wegovy through a private route covers what to look for in a legitimate provider. For context on what private treatment typically costs and what a quoted price should include, the Wegovy cost guide is a useful reference before you commit.

For men considering treatment, the consultation is the right place to start. There is no obligation, no auto-renewal and no pressure. If Wegovy is not the right fit clinically, a prescriber can say so and discuss what the options are.